Immunology/Inflammation(免疫及炎症)
The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.
Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].
BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].
Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.
Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].
References
[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.
[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.
[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.
[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.
[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.
[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.
[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.
[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.
Products for Immunology/Inflammation
- 5-Lipoxygenase(10)
- Papain(1)
- PGDS(1)
- PGE synthase(24)
- SIKs(10)
- IκB/IKK(63)
- AP-1(3)
- KEAP1-Nrf2(63)
- NOD1(1)
- TLR(125)
- NF-κB(226)
- Interleukin Related(144)
- 15-lipoxygenase(2)
- Others(63)
- Aryl Hydrocarbon Receptor(32)
- CD73(14)
- Complement System(51)
- Galectin(10)
- IFNAR(21)
- NO Synthase(73)
- NOD-like Receptor (NLR)(45)
- STING(97)
- Reactive Oxygen Species(436)
- Apoptosis(631)
- FKBP(19)
- eNOS(5)
- iNOS(28)
- nNOS(20)
- Glutathione(52)
- Adaptive Immunity(206)
- Allergy(125)
- Arthritis(32)
- Autoimmunity(175)
- Gastric Disease(91)
- Immunosuppressants(36)
- Immunotherapeutics(4)
- Innate Immunity(552)
- Pulmonary Diseases(110)
- Reactive Nitrogen Species(49)
- Reactive Sulfur Species(26)
- Specialized Pro-Resolving Mediators(50)
- Cyclic GMP-AMP Synthase(2)
- Cat.No. 产品名称 Information
-
GC68709
Avizakimab
BOS161721
Avizakimab (BOS161721) 是一种人源化 IgG1 单克隆抗体,靶向白介素-21 (IL-21)。 -
GC68702
Astegolimab
艾特利单抗; MSTT 1041A; RG 6149
Astegolimab (MSTT 1041A; RG 6149) 是一种人 IgG2 单克隆抗体,可通过靶向 IL-33 受体 ST2 来阻断 IL-33 信号传导。Astegolimab 具有用于慢性阻塞性肺疾病 (COPD) 研究的潜力。 - GC68700 ASR-488 ASR-488 可激活 mRNA 结合蛋白 CPEB1,诱导细胞凋亡 (apoptosis) 并抑制膀胱癌的生长。
- GC68649 Amaroswerin Amaroswerin 是一种从獐牙菜中提取的具有生物活性的硫环烯醚萜苷。Amaroswerin 具有抗炎、抗糖尿病、抗病毒、抗胆碱能和免疫调节活性。在 RAW264.7 细胞中,Amaroswerin 抑制 NO 释放,IC50 值为 5.42 μg/mL。
- GC68632 AK-778-XXMU AK-778-XXMU是DNA结合2 (ID2) 拮抗剂的有效抑制剂,KD为129 nM。AK-778-XXMU 能抑制胶质瘤细胞株的迁移和侵袭,诱导细胞凋亡 (apoptosis),更重要的是能减缓肿瘤生长。
- GC68631 AhR agonist 2 AhR agonist 2 (Compound 12a) 是一种有效的芳烃受体 (AhR) 激动剂,EC50 为 0.03 nM。AhR agonist 2 诱导 AhR 的快速核富集,触发下游基因的转录并促进皮肤屏障修复。AhR agonist 2 具有研究银屑病的潜力。
-
GC68595
Abrezekimab
UCB4144; VR 942
Abrezekimab (VR 942) 含有 CDP7766,这是一种人源化、高亲和力、中和性、抗人 IL-13 抗体片段,可与 IL-13 结合。Abrezekimab 阻止与 IL-13Rα1 亚基的结合。Abrezekimab 可用于哮喘的研究。 - GC68576 6'-Sialyllactose 6'-Sialyllactose 是一种唾液酸化的人乳低聚糖,可以促进双歧杆菌的增殖并塑造肠道菌群。6'-Sialyllactose 还抑制 toll-like receptor 4 信号转导并防止坏死性小肠结肠炎的发展。
-
GC68562
5-Aminolevulinic acid-13C-1 hydrochloride
5-ALA-13C-1 hydrochloride; δ-Aminolevulinic acid-13C-1 hydrochloride; 5-Amino-4-oxopentanoic acid-13C-1 hydrochloride
5-Aminolevulinic acid-13C-1 (5-ALA-13C-1) hydrochloride 是 13C 标记的 5-Aminolevulinic acid hydrochloride。5-Aminolevulinic acid hydrochloride (5-ALA hydrochloride) 是体内血红素生物合成的中间体,为四吡咯的前体。 -
GC20228
α-Amyrin
α-香树脂醇
α-香树脂醇是一种五环三萜类化合物。
-
GC20142
Beta-Sitosterol (purity>98%)
β-谷甾醇 (purity>98%); β-Sitosterol (purity>98%); 22,23-Dihydrostigmasterol (purity>98%))
- GP26368 Tri a 14.0101 Recombinant Non-Specific Lipid-Transfer Protein Tri a 14 produced in SF9 is a glycosylated, polypeptide chain having a calculated molecular mass of 13kDa
- GP26367 Pen a 1.0101 Recombinant Tropomyosin Pen a 1
- GP26366 MALD3 Recombinant Non-Specific Lipid-Transfer Protein Mal d 3 produced in SF9 is a glycosylated, polypeptide chain having a calculated molecular mass of 12kDa
- GP26365 Cor a 14.0101 Recombinant 2S albumin produced in SF9 is a glycosylated, polypeptide chain having a calculated molecular mass of 14kDa
- GP26364 Cor a 9 The native protein Corylus Avellana Cor a 9 is purified from hazelnut by protein chemical methods
- GP26363 Cor a 8.0101 Recombinant Non-specific Lipid-Transfer Protein Cor a 8 produced in SF9 is a glycosylated, polypeptide chain having a calculated molecular mass of 11kDa
- GP26025 LGALS3 Mouse, Active LGALS3 Mouse Recombinant produced in E
- GP26024 LGALS2 Mouse, Active LGALS2 Mouse Recombinant produced in E
- GC26091 ZLc002 ZLc-002 is a selective inhibitor of nNOS-Capon coupling. ZLc-002 suppresses inflammatory nociception and chemotherapy-induced neuropathic pain.
-
GC25314
CU-CPD107
CU-CPD107 is a selective, dual-activity small-molecule which demonstrated differential activity against the TLR8 agonists and ssRNA ligands.
-
GC25014
3',3'-cGAMP
3',3'-cyclic GMP-AMP, Cyclic GMP-AMP, cGAMP
3',3'-cGAMP (3',3'-cyclic GMP-AMP, Cyclic GMP-AMP, cGAMP) activates the endoplasmic reticulum (ER)-resident receptor stimulator of interferon genes (STING), thereby inducing an antiviral state and the secretion of type I IFNs. - GC68461 TrxR-IN-5 TrxR-IN-5 (化合物 4f) 是一种有效的 TrxR 硫氧还蛋白还原酶抑制剂,其 IC50 值为 0.16 μM。TrxR-IN-5 增加 ROS 水平,从而产生有效的抗增殖作用。TrxR-IN-5 具有显著的抗肿瘤和抗转移作用。
-
GC68452
2,4,6-Triiodophenol
2,4,6-三碘酚
2,4,6-Triiodophenol 是一种具有口服活性的、强效的 leukotriene B4 (LTB4) 合成抑制剂。2,4,6-Triiodophenol 可诱导小鼠囊胚凋亡。 - GC68432 DB-3-291 DB-3-291 是一种有效和选择性的 CSK 降解剂,Kd 值为 1 nM。
- GC68386 CD73-IN-5 CD73-IN-5 是一种有效且选择性的非核苷酸小分子 CD73 抑制剂(IC50 = 19 nM)。
-
GC68379
L-Arginine-13C6,15N4 hydrochloride
(S)-(+)-Arginine-13C6,15N4 hydrochloride
L-Arginine-13C6,15N4 ((S)-(+)-Arginine-13C6,15N4) hydrochloride 是带有 13C 标记和 15N 标记的 L-Arginine hydrochloride。L-Arginine hydrochloride ((S)-(+)-Arginine hydrochloride) 为合成一氧化氮的氮供体,是血管扩张剂。 -
GC68346
Uliledlimab
TJ004309
Uliledlimab 是一种有效的抗 CD73 人源单克隆抗体。Uliledlimab 抑制胞外单磷酸腺苷 (AMP) 向腺苷的转化。Uliledlimab 可用于癌症的研究。 -
GC68344
Mupadolimab
CPI-006
Mupadolimab (CPI-006) 是一种 IgG1κ 人源化的 FcγR 结合缺陷抗 CD73 单抗,激活 CD73POS B 细胞。 -
GC68341
Nemolizumab
CIM331
Nemolizumab (CIM331) 是一种人源化的抗人白细胞介素-31 受体 a 单克隆抗体,可抑制白细胞介素-31 (IL-31) 与其受体的结合和随后的信号转导。Nemolizumab 可用于特应性皮炎 (AD) 的研究。 -
GC68336
Siltuximab
CNTO-328
Siltuximab 是一种 anti-IL-6 (interleukin-6) 单克隆抗体,具有抗肿瘤活性。Siltuximab 可用于多中心性巨大淋巴结增生症 (MCD) 和 COVID-19 的研究。 -
GC68308
Bisdemethoxycurcumin-d8
Curcumin III-d8; Didemethoxycurcumin-d8
Bisdemethoxycurcumin-d8 (Curcumin III-d8) 是 Bisdemethoxycurcumin 的氘代物。Bisdemethoxycurcumin 是姜黄素衍生物,具有抗炎症和抗癌活性。 - GC68306 Deoxynyboquinone Deoxynyboquinone 是 NQO1 的底物,是有效的抗癌剂。Deoxynyboquinone 诱导癌症细胞凋亡 (Apoptosis)。Deoxynyboquinone 通过氧化应激和活性氧 (ROS) 的形成杀死癌细胞。
- GC68294 ODN 1668 ODN 1668 是 B 类 CpG ODN (寡脱氧核苷酸),是一种 TLR-9 激动剂。 ODN 1668 是一种免疫刺激序列,可作为疫苗佐剂。 序列:5'-tccatgacgttcctgatgct-3'。
- GC68293 ODN 1585 ODN 1585 是一种有效的 IFN 和TNFα 产生诱导剂。ODN 1585 是一种有效的 NK (自然杀手)刺激剂。ODN 1585 增加 CD8+ T 细胞的功能,包括 CD8+ T 细胞介导的 IFN-γ 的产生。ODN 1585诱导小鼠已建立的黑色素瘤消退。ODN 1585 对小鼠的疟疾具有完全的保护作用。ODN 1585 可用于急性骨髓性白血病 (AML) 和疟疾研究。ODN 1585 可作为疫苗佐剂。
- GC68292 ODN 2395 ODN 2395 是一种 C 类寡核苷酸,可用作疫苗佐剂。ODN 2395 也是一种 TLR9 激动剂。序列:5'-tcgtcgttttcggcgc:gcgccg-3'。(注:碱基为硫代磷,ODN 2395包含部分回文序列cggcgc:gcgccg)
-
GC68230
MitoSOX Red
MitoSOX Red是一种靶向线粒体的活细胞荧光探针,最大激发光/发射光为510/580 nm。
- GC68213 MitoBloCK-6 MitoBloCK-6 是一种有效的 Erv1/ALR 抑制剂,IC50 分别为 900 nM 和 700 nM。MitoBloCK-6 还抑制 Erv2 (IC50=1.4 μM)。MitoBloCK-6 可通过细胞色素 c 的释放诱导 hESCs 细胞凋亡。
- GC68141 SEMBL SEMBL 是一种有效的 NF-κB 抑制剂。SEMBL 能够抑制 NF-κB-DNA 结合,还抑制 NF-κB 依赖性炎性细胞因子分泌。SEMBL 通过降低 MMP 表达来抑制癌细胞的迁移和侵袭。可用于抗癌研究。
- GC68081 3-Amino-1,2,4-triazine 3-Amino-1,2,4-triazine 是 NO 合成酶 (NO Synthase) 抑制剂,也能抑制亚硝酸盐的分泌。
-
GC68051
Citric acid-d4
柠檬酸 d4
Citric acid-d4 是 Citric acid 的氘代物。Citric acid 是柑橘类水果中发现的弱有机三羧酸。柠檬酸是天然防腐剂和食品添加剂。 -
GC68044
2,4,6-Trihydroxybenzaldehyde
2,4,6-三羟基苯甲醛
2,4,6-Trihydroxybenzaldehyde 是一种具有口服活性的 NF-?B 抑制剂。2,4,6-Trihydroxybenzaldehyde 具有抗肿瘤活性、抗癌细胞增殖活性和抗肥胖活性。 - GC68043 2-tert-Butyl-1,4-benzoquinone 2-tert-Butyl-1,4-benzoquinone 是 butylated hydroxyanisole 的亲电代谢产物,是 2-tert-butylhydroquinone 的氧化产物。
-
GC68039
Chlorin e6 trimethyl ester
二氢卟吩 e6 三甲酯
Chlorin e6 trimethyl ester,是甲基脱镁叶绿酸-a 的衍生物,是一种可用于光动力疗法 (PDT) 的光敏剂。 - GC68029 JPE-1375 JPE-1375 是一种补体 C5a 受体 1 (C5aR1) 拮抗剂。JPE-1375 能有效抑制小鼠体内多形核白细胞动员 (EC50=6.9 µM) 和降低 TNF 水平 (EC50=4.5 µM)。JPE-1375 可用于自身免疫性和炎性疾病的研究。
- GC67968 ALPK1-IN-2 ALPK1-IN-2 (化合物 T001) 是一种有效的 ALPK1 (α- 激酶 1) 抑制剂,其 IC50 值为 95 nM。ALPK1-IN-2 还抑制 NF-κB,IC50 值为 1.31 μM。
- GC67966 Methylstat Methylstat 是一种有效的组蛋白去甲基化酶 (histone demethylases) 抑制剂。Methylstat 具有抗增殖活性,低细胞毒性。Methylstat 诱导细胞凋亡 (Apoptosis) 和细胞周期停滞在 G0/G1 期。Methylstat 增加 p53 和 p21 蛋白水平的表达。Methylstat 抑制由各种细胞因子诱导的血管生成。Methylstat 可用作化学探针以解决其在血管生成中的作用。
-
GC67936
Lupiwighteone
黄羽扇豆魏特酮; 8-prenylgenistein
Lupiwighteone 是一种广泛存在于野生植物中的异黄酮,具有抗氧化、抗菌和抗癌作用。Lupiwighteone 通过抑制 PI3K/Akt/mTOR 通路,诱导人乳腺癌细胞 caspase 依赖性和非依赖性凋亡 (Apoptosis)。 - GC67903 RIDR-PI-103 RIDR-PI-103 是一种活性氧 (ROS) 诱导的药物释放前药,具有与泛 PI3K 抑制剂 (PI-103) 连接的自环化部分。Doxorubicin 和 RIDR-PI-103 在 MDA-MB-361 和 MDA-MB-231 细胞中显示出抑制癌细胞增殖的协同作用。
- GC67892 CHD-5 CHD-5 是一种有效的 AhR (芳香烃受体)拮抗剂。